Therefore, in women without breast cancer, if melatonin alone or combined with HT similarly reduces amphiregulin expression as in the mice, breast tissue may be less stimulated by EGFR/HER2 signaling and less prone to carcinogenesis; and, amphiregulin may influence both the initiation and promotion phases of tumor development. The gene discussed is ERBB2; the disease is breast cancer.